« Back to Record
Citation APA

Clumeck, N., Mwamba, C., Kabeya, K., Mafutamingi, J., Vaira, D., Ilunga, K., Necsoi, C. V., Milolo, C., De Wit, S., Muyumba, E., Moutschen, M., Kasamba, E., Delforge, M.-L., & Kapend, L. (2011). The Lubumbashi Trial: Week 48 Data: Comparison between Lopinavir/r (LPV/r) versus Nevirapine (NVP)-based Regimens in Treatment-naïve Patients in a Developing Country. Paper session presented at European AIDS Conference / EACS (13: October 12-15 2011: Belgrade, Serbia).


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/225077

Clumeck, N., Mwamba, C., Kabeya, K., Mafutamingi, J., Vaira, D., Ilunga, K., Necsoi, C. V., Milolo, C., De Wit, S., Muyumba, E., Moutschen, M., Kasamba, E., Delforge, M.-L., & Kapend, L. (2011). The Lubumbashi Trial: Week 48 Data: Comparison between Lopinavir/r (LPV/r) versus Nevirapine (NVP)-based Regimens in Treatment-naïve Patients in a Developing Country. Paper session presented at European AIDS Conference / EACS (13: October 12-15 2011: Belgrade, Serbia).